The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ARS PHARMACEUTICALS INC | COM | 82835W108 | 19,520,496 | 1,910,029 | SH | SOLE | 1,910,029 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 58,138,504 | 1,408,394 | SH | SOLE | 1,408,394 | 0 | 0 | ||
BOUNDLESS BIO INC | COM | 10170A100 | 17,499,983 | 1,228,069 | SH | SOLE | 1,228,069 | 0 | 0 | ||
CARGO THERAPEUTICS INC | COM | 14179K101 | 58,980,645 | 2,642,502 | SH | SOLE | 2,642,502 | 0 | 0 | ||
CULLINAN ONCOLOGY INC | COM | 230031106 | 20,808,311 | 1,221,145 | SH | SOLE | 1,221,145 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 17,276,318 | 3,856,321 | SH | SOLE | 3,856,321 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 72,678,568 | 5,285,714 | SH | SOLE | 5,285,714 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 31,925,195 | 3,846,409 | SH | SOLE | 3,846,409 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 202,943,930 | 6,296,740 | SH | SOLE | 6,296,740 | 0 | 0 | ||
SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 20,571,840 | 952,400 | SH | SOLE | 952,400 | 0 | 0 | ||
TANGO THERAPEUTICS INC | COM | 87583X109 | 43,939,801 | 5,533,980 | SH | SOLE | 5,533,980 | 0 | 0 | ||
TYRA BIOSCIENCES INC | COM | 90240B106 | 66,516,120 | 4,055,861 | SH | SOLE | 4,055,861 | 0 | 0 |